跳至主要内容
临床试验/CTRI/2024/09/073699
CTRI/2024/09/073699尚未招募3 期

A Randomized Controlled Clinical Trial to evaluate the effect of Vachaharidradi Ghana Vati in the management of Dyslipidemia

Dr K R Sreeranjani1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年9月10日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Reduction in Lipid Profile

研究概览

简要总结

Dyslipidemia is manifested by the elevation of total cholestrol low density lipoprotein cholestrol triglycerides and a decrease in the high density lipoprotein cholestrol

Dyslipidemia has no specific signs and symptoms

In Ayurveda the concept of Dyslipidemia goes in parallel with Medorogam. Ati Santarpana leads to Kapha Vriddhi;

Dushti of Rasa and Medo Dhathu. Medorogam occurs due to Medo Dhathu Dushti which

causes Medo Dhathvagni Mandhyam. The treatment should aim at Apatarpana, Ama

Pachana, Srotoshodhana and Kapha Medohara Chikitsa which helps in attaining Samyata of

Dosha and Dushya. VachaHaridradi Gana contains Vacha, Musta, Devadaru, Nagara,

Ativisha, Haritaki, Haridra, Daruharidra, Yashtimadhu, Prishniparni and Kutaja. It is Katu,

Tikta Rasayuktha. Due to Laghu Ruksha Guna, it does Medoshoshana; it is Ushna in Virya

and Katu in Vipaka and Kapha Medahara in nature. It is Pachana, Deepanam, Kleda-Meda

Shoshaka, Srotovishodaka and Lekhana in nature. It is found that drugs like Vacha, Musta

and Ativisha have hypolipidemic properties.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 64.00 Year(s)(—)
性别
All

入选标准

  • subjects between age of 18 to 64 years of age.
  • Patients Fulfilling the diagnostic and pre diagnosed patients with dyslipidemic range total cholestrol 200 to 239 mg per dl LDL 129 to 159 mg per dl Triglyceride 150 to 199 mg per dl HDL less than 40 mg per dl QRISK Value less than 10 percentage.

排除标准

  • known case of primary dyslipidemia, coronary artery disease, cerebrovascular accident, peripheral artery disease carcinomas renal disorders like chronic kidney disease and nephrotic syndrome hepatic disorders like liver cirrhosis, steatotic liver disease, hypothyroidism, hypertension, diabetes mellitus Dyslipidemia due to consumption of drugs like glucocorticoids and diuretics pregnant and lactating women.

结局指标

主要结局

Reduction in Lipid Profile

时间窗: 31 days

次要结局

未报告次要终点

研究者

发起方
Dr K R Sreeranjani
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr K R Sreeranjani

Sri Jayendra Saraswathi Ayurveda College and Hospital

研究点 (1)

Loading locations...

相似试验